Lianping Ti

2.8k total citations
128 papers, 2.0k citations indexed

About

Lianping Ti is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Lianping Ti has authored 128 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Epidemiology, 72 papers in Public Health, Environmental and Occupational Health and 38 papers in Infectious Diseases. Recurrent topics in Lianping Ti's work include HIV, Drug Use, Sexual Risk (80 papers), Opioid Use Disorder Treatment (69 papers) and HIV/AIDS Research and Interventions (36 papers). Lianping Ti is often cited by papers focused on HIV, Drug Use, Sexual Risk (80 papers), Opioid Use Disorder Treatment (69 papers) and HIV/AIDS Research and Interventions (36 papers). Lianping Ti collaborates with scholars based in Canada, United States and France. Lianping Ti's co-authors include Evan Wood, Thomas Kerr, Kanna Hayashi, Samuel Tobias, Jane A. Buxton, Mark Lysyshyn, Paisan Suwannawong, Karyn Kaplan, M‐J Milloy and Julio Montaner and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Epidemiology.

In The Last Decade

Lianping Ti

122 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianping Ti Canada 23 1.3k 996 422 398 267 128 2.0k
María J. Bravo Spain 25 1.9k 1.5× 1.8k 1.8× 352 0.8× 364 0.9× 336 1.3× 77 2.9k
Nadia Fairbairn Canada 30 1.9k 1.5× 1.8k 1.8× 483 1.1× 397 1.0× 428 1.6× 118 2.8k
M. Eugenia Socías Canada 30 1.3k 1.0× 920 0.9× 823 2.0× 197 0.5× 340 1.3× 145 2.8k
Stephen Koester United States 23 1.2k 1.0× 998 1.0× 418 1.0× 123 0.3× 427 1.6× 43 2.0k
Robin A. Pollini United States 31 2.0k 1.6× 1.2k 1.2× 864 2.0× 178 0.4× 471 1.8× 80 2.8k
Lauretta E. Grau United States 21 931 0.7× 687 0.7× 288 0.7× 106 0.3× 226 0.8× 74 1.5k
Lynn D. Wenger United States 26 1.2k 1.0× 1.0k 1.0× 296 0.7× 229 0.6× 298 1.1× 95 1.6k
Luis Sordo Spain 20 1.5k 1.2× 1.7k 1.8× 198 0.5× 205 0.5× 356 1.3× 89 2.7k
April M. Young United States 25 1.3k 1.0× 997 1.0× 427 1.0× 64 0.2× 465 1.7× 125 2.2k
Jack Stone United Kingdom 18 2.1k 1.6× 850 0.9× 853 2.0× 107 0.3× 227 0.9× 59 2.6k

Countries citing papers authored by Lianping Ti

Since Specialization
Citations

This map shows the geographic impact of Lianping Ti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianping Ti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianping Ti more than expected).

Fields of papers citing papers by Lianping Ti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianping Ti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianping Ti. The network helps show where Lianping Ti may publish in the future.

Co-authorship network of co-authors of Lianping Ti

This figure shows the co-authorship network connecting the top 25 collaborators of Lianping Ti. A scholar is included among the top collaborators of Lianping Ti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianping Ti. Lianping Ti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ti, Lianping, et al.. (2024). Opportunities and challenges for implementing drug checking services in British Columbia, Canada: A qualitative study. International Journal of Drug Policy. 132. 104560–104560. 2 indexed citations
4.
Ti, Lianping, et al.. (2023). Development of a neural network model to predict the presence of fentanyl in community drug samples. PLoS ONE. 18(7). e0288656–e0288656. 3 indexed citations
5.
Tobias, Samuel, Mark Lysyshyn, Jane A. Buxton, et al.. (2023). What impact did the COVID-19 pandemic have on the variability of fentanyl concentrations in the Vancouver, Canada illicit drug supply? An interrupted time-series analysis. SHILAP Revista de lepidopterología. 1(1). e000197–e000197. 8 indexed citations
6.
Tobias, Samuel, Heather Palis, Charlene Burmeister, et al.. (2023). Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study. International Journal of Drug Policy. 123. 104290–104290. 6 indexed citations
7.
Socías, M. Eugenia, et al.. (2022). Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies. Drug and Alcohol Review. 42(3). 538–543. 13 indexed citations
8.
9.
Nolan, Seonaid, et al.. (2022). Improving opioid stewardship programs through shared decision-making. Journal of the American Pharmacists Association. 62(3). 697–700. 5 indexed citations
10.
Wood, Evan, et al.. (2021). Is expected substance type associated with timing of drug checking service utilization?: A cross-sectional study. Harm Reduction Journal. 18(1). 66–66. 13 indexed citations
11.
Tobias, Samuel, et al.. (2020). Drug checking identifies counterfeit alprazolam tablets. Drug and Alcohol Dependence. 218. 108300–108300. 43 indexed citations
12.
Hayashi, Kanna, Huiru Dong, Kora DeBeck, et al.. (2020). Impact of migration from an illicit drug scene on hospital outcomes among people who use illicit drugs in Vancouver, Canada. Drug and Alcohol Review. 39(7). 924–931. 1 indexed citations
13.
Nolan, Seonaid, et al.. (2020). The impact of high-dose opioid prescription on mortality rates among people living with HIV: A retrospective cohort study. International Journal of Drug Policy. 78. 102705–102705. 3 indexed citations
14.
Ti, Lianping, Nadia Fairbairn, Keith Ahamad, et al.. (2020). Building a hospital‐based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned. Addiction. 116(7). 1892–1900. 18 indexed citations
15.
Lima, Viviane D., et al.. (2019). Impact of personality disorders on leaving hospital against medical advice among people living with HIV in British Columbia, Canada. Social Psychiatry and Psychiatric Epidemiology. 54(9). 1153–1159. 5 indexed citations
16.
Hayashi, Kanna, Pauline Voon, Hennady P. Shulha, et al.. (2019). Characterising the association between positive hepatitis C virus antibody and pain among people who inject drugs. Drug and Alcohol Review. 38(6). 639–643. 3 indexed citations
17.
Clark, Jessica, Nadia Fairbairn, Seonaid Nolan, et al.. (2019). Prescription of High-Dose Opioids Among People Living with HIV in British Columbia, Canada. AIDS and Behavior. 23(12). 3331–3339. 1 indexed citations
18.
Ma, Huiting, Oghenowede Eyawo, M. Ruth Lavergne, et al.. (2018). The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study. BMC Health Services Research. 18(1). 319–319. 2 indexed citations
19.
Hayashi, Kanna, M‐J Milloy, Evan Wood, et al.. (2018). Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada. Substance Abuse Treatment Prevention and Policy. 13(1). 27–27. 12 indexed citations
20.
Ti, Lianping, et al.. (2018). Hepatitis C virus infection and hospital-related outcomes: a systematic review protocol. BMJ Open. 8(6). e021118–e021118. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María J. Bravo Breakdown of academic impact, for papers by Nadia Fairbairn Breakdown of academic impact, for papers by M. Eugenia Socías Breakdown of academic impact, for papers by Stephen Koester Breakdown of academic impact, for papers by Robin A. Pollini Breakdown of academic impact, for papers by Lauretta E. Grau Breakdown of academic impact, for papers by Lynn D. Wenger Breakdown of academic impact, for papers by Luis Sordo Breakdown of academic impact, for papers by April M. Young Breakdown of academic impact, for papers by Jack Stone
Rankless by CCL
2026